Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atomic Capital is a Mumbai-based early-stage venture capital firm that operates with a hands-on "Operating VC" model to support high-growth consumer and consumer-tech brands in India. Founded in 2024, the firm focuses on capital-efficient businesses that have achieved product-market fit, providing not only financial backing but also deep operational and strategic guidance. Its portfolio includes several healthcare-adjacent and wellness brands, such as the science-backed skincare company Conscious Chemist. Atomic Capital typically invests in Pre-Series A and Series A rounds, aiming to build a curated portfolio of market-leading consumer winners. The firm distinguishes itself by working closely with founders on weekly rhythms to drive predictable and scalable execution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atomic Capital.